glp1 journey and tirzepatide dosage Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are glp1 journey and tirzepatide dosage

Beginning July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) will launch the Medicare GLP-1 Bridge Program, a temporary demonstration designed to provide eligible Medicare Part D beneficiaries with access to certain GLP-1 medications through December 31, 2027

doi: 10.1159/000318958 13

Treatment Tirzepatide is primarily used for the treatment of type 2 diabetes and obesity

Weekly weighing prevents getting discouraged by daily fluctuations while providing enough data points to identify trends

Mounjaro GLP-1 This injectable medication, personalized for each patient, mimics a natural hormone in appetite regulation and glucose control

It has also been suggested that TB-500 has anti-apoptotic properties